Bohan Wei
Vice President of Corporate Development
Replay available
Palvella Therapeutics, Inc. (PVLA) Q4 2025 Earnings Call
Palvella Therapeutics, Inc. (NASDAQ: PVLA) Q4 2025 earnings conference call, held 2026-03-31. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Wes Coffinan
Founder & Chief Executive Officer
Dr. Jeff Martini
Chief Scientific Officer
Matt Korenberg
Chief Financial Officer
Josh Shimmer
Analyst, Kantor
Ritu Baral
Analyst, T.D. Cowen
Annabel Simini
Analyst, Stifel
Ryan Reese
Analyst, Mizuho
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Palvella Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.096 Good day and thank you for standing by. Welcome to the Povella Therapeutics full year 00:00:04.096 -- 00:00:09.202 2025 financial results conference call. At this time, all participants are in a listen-only 00:00:09.202 -- 00:00:14.028 mode. After the speaker's presentation, there will be a question and answer session. 00:00:14.028 -- 00:00:18.774 To ask a question during the session, you'll need to press star 1-1 on your telephone. 00:00:18.774 -- 00:00:22.459 You will then hear an automated message advising your hand is raised. 00:00:22.459 -- 00:00:25.383 To withdraw your question, please press star 1-1 again. 00:00:25.383 -- 00:00:29.798 Please be advised that today's conference is being recorded. 00:00:29.798 -- 00:00:33.743 I'd now like to hand the conference over to Bohan Wei, Vice President of Corporate Development. 00:00:33.743 -- 00:00:35.866 Please go ahead. 00:00:35.866 -- 00:00:39.991 Thank you, Operator. Good morning, and thank you for joining the Palvela Therapeutics 00:00:39.991 -- 00:00:44.337 full year 2025 financial results and corporate update call. 00:00:44.337 -- 00:00:48.022 As a reminder, our press release detailing today's announcements can be found in the 00:00:48.022 -- 00:00:52.505 investor section of our website at www.palvelatx.com. 00:00:54.069 -- 00:00:57.954 On today's call, you will first hear from Wes Coffinan, our Founder and Chief Executive 00:00:57.954 -- 00:01:03.240 Officer, followed by Dr. Jeff Martini, our Chief Scientific Officer, and Matt Korenberg, 00:01:03.240 -- 00:01:07.825 our Chief Financial Officer. Wes will return for closing remarks before we open the line 00:01:07.825 -- 00:01:09.986 for Q&A. 00:01:10.629 -- 00:01:14.494 Before we begin, please note that today's remarks may incl...